Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Congresswoman Ayanna Pressley (D-Mass.) Announced She has Alopecia Areata; Search Still on for Holy Grail of Hair Regrowth

Dermatologist Dr. Joshua Fox with Advanced Dermatology PC Offers Tips on Protecting Hair, Preventing Alopecia


News provided by

Advanced Dermatology PC

Mar 15, 2021, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Joshua Fox
Dr. Joshua Fox

ROSLYN, N.Y., Mar. 15, 2021 /PRNewswire-PRWeb/ -- Going, going, gone! When it comes to loss of hair, finding the right elixir to bring it back has become akin to the search for the Holy Grail, yet scientists seem closer to understanding causes of alopecia – balding -- and developing more effective strategies for treating it, says noted dermatologist Joshua Fox MD.

"But solutions cannot come quickly enough," adds Dr. Fox, founder and medical director of Advanced Dermatology, PC, and the Center for Laser & Cosmetic Surgery, with offices in New York, New Jersey, and Pennsylvania. "Not only do millions of men and women in this country experience some degree of hair loss, balding is sometimes associated with other medical disorders and can have a serious psychological effect on a person's self-image and quality of life."

The disease is characterized by non-scarring hair loss that usually occurs in patches on the scalp and occasionally elsewhere on the body.

Post this

Dr. Fox refers specifically to alopecia areata, which develops when the body's own immune system begins attacking the hair follicles. The disease is characterized by non-scarring hair loss that usually occurs in patches on the scalp and occasionally elsewhere on the body. Scientists call alopecia areata "the most prevalent autoimmune disorder" and one of the most common causes of hair loss – second only to androgenetic alopecia, the hereditary form of balding. Alopecia areata is oftentimes linked to psychiatric problems like depression and anxiety and to other autoimmune diseases, including rheumatoid arthritis, systemic lupus, type I diabetes, and thyroid disorders.

At least one very recent study, appearing in the Journal of Dermatology, finds an association between alopecia, especially alopecia areata, and inflammatory bowel disease.

It may not be life-threatening, but alopecia certainly is an "old" problem, with the search for a "cure" dating 3,500 years or more. The Romans blamed heavy metal helmets for the rash of balding soldiers in their military. Much more recently, studies have shown that various medical conditions, such as infections, thyroid disease, lifestyle factors – obesity, an unhealthy diet, and poor hair management and styling habits; advancing age; and family history are all risk factors for alopecia.

Balding, in fact, became news in 2020 when Congresswoman Ayanna Pressley (D-Mass.), well known for turning her Senegalese hair twists into a kind of political brand, announced she had been diagnosed as having alopecia areata and was experiencing significant hair loss. Many people are so embarrassed by their Alopecia conditions that they require wigs or hair coverings.

For some 50 million men and 30 million women in the United States, alopecia is hereditary; it is in their genes, according to the American Academy of Dermatology. Dr. Fox, however, expresses concern about a lesser-known cousin – frontal fibrosing alopecia (FFA). He cites recent reports, including a 2018 study in the British Journal of Dermatology and a scientific presentation at an American Academy of Dermatology conference, indicating that incidence of FFA is increasing at an alarming rate. Some researchers even suggest the disorder may reach epidemic proportions.

FFA primarily affects postmenopausal women and leads to scarring and permanent destruction of hair follicles. Typical signs of the disorder are balding at the frontal and temporal areas of the scalp and around the ears. Many patients also experience loss of eyebrows. Researchers suspect a possible link between FFA and use of sunscreens with zinc and facial skin-care products and moisturizers, Dr. Fox relates.

Scientists continue the scramble to find the one or two medications, therapies, or approaches that might work, and work well, for most alopecia patients – at least for patients like Cong. Pressley who have specific types of the disorder. As of today, the FDA has approved use of only two hair-loss drugs – minoxidil, which is usually applied topically, and finasteride, which is taken orally. Both medications have had varying degrees of success in promoting hair regrowth for various types of alopecia; finasteride is associated with unwanted side effects involving sexual function in men.

An article in a 2020 edition of the Journal of Investigative Dermatology Symposium Proceedings reports that clinical trials of Jak inhibitors for treatment of alopecia areata have "increased significantly." Studies have determined that Jak inhibitors – chemicals inhibiting the activity of specific enzymes that "talk" to the immune system's T-cells – can actually reverse alopecia areata, cause hair follicle stem cells to proliferate, and move hair follicles from a "resting" to a "growth" phase, Dr. Fox explains.

Meanwhile, Dr. Fox says dermatologists will continue to rely on a combination of treatment "standards," including medications – steroids, hair-growth chemicals, estrogen, and immunologic agents – given topically, orally and by intradermal injection; injections of platelet-rich plasma; low-level laser and ultraviolet light therapies to stimulate blood circulation in areas of hair loss; and hair transplantation, a procedure that does not grow new hair, but only redistributes healthy hair to bald areas.

Not all balding can be prevented, Dr. Fox emphasizes, but the risks of developing some forms of alopecia can be minimized. He offers these tips:

  • Avoid stressing hair with hot dryers or curlers, coloring, permanents, cosmetics filled with chemicals, and styles – like tight braids and ponytails – that pull on the hairline.
  • Wash regularly with basic shampoos that are right for one's hair texture.
  • Brush hair gently with full strokes – from the scalp to the ends of the hair; use a brush that does not tear the hair.
  • Massage the scalp frequently to promote blood circulation and hair growth might help.
  • Improve your diet. Eat raw vegetables and foods rich in protein and vitamin A.
  • If you do notice some hair loss, contact a dermatologist for examination; treatment, if needed; and advice.
  • Some suggest Nutrafol which may help stimulate hair growth.

"The Holy Grail of hair regrowth is still out there. As physicians and scientists, we intend to find it -- eventually," says Dr. Fox.

Joshua Fox, MD, FAAD, is a dermatologist, with specialty interest in cosmetic surgery, laser procedures and the treatment of skin cancers. In practice for nearly 40 years, Dr. Fox is the recipient of numerous professional and research honors, including the Husic Award for most outstanding research. He founded Advanced Dermatology P.C. and the Center for Laser and Cosmetic Surgery (New York, New Jersey, and Pennsylvania) in 1986, turning it into one of the leading dermatology centers in the nation. http://www.advanceddermatologypc.com.

Media Contact

Melissa Chefec, MCPR, LLC, 2039686625, [email protected]

SOURCE Advanced Dermatology PC

Related Links

http://www.advanceddermatologypc.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.